Search

Vanessa L. Ford

Supervisory Patent Examiner (ID: 6966, Phone: (571)272-0857 , Office: P/1646 )

Most Active Art Unit
1645
Art Unit(s)
1645, 1646, 1674
Total Applications
502
Issued Applications
154
Pending Applications
66
Abandoned Applications
291

Applications

Application numberTitle of the applicationFiling DateStatus
09/526344 Genetically stable cholera vaccines Mar 15, 2000 Abandoned
09/524315 Cancer vaccines Mar 12, 2000 Abandoned
Array ( [id] => 971875 [patent_doc_number] => 06936260 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-30 [patent_title] => 'Vaccine composition' [patent_app_type] => utility [patent_app_number] => 09/926001 [patent_app_country] => US [patent_app_date] => 2000-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3155 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936260.pdf [firstpage_image] =>[orig_patent_app_number] => 09926001 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/926001
Vaccine composition Feb 8, 2000 Issued
Array ( [id] => 1017648 [patent_doc_number] => 06890540 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Vaccine formulation' [patent_app_type] => utility [patent_app_number] => 09/926002 [patent_app_country] => US [patent_app_date] => 2000-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3302 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890540.pdf [firstpage_image] =>[orig_patent_app_number] => 09926002 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/926002
Vaccine formulation Feb 8, 2000 Issued
Array ( [id] => 630133 [patent_doc_number] => 07132108 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-07 [patent_title] => 'Biodegradable and biocompatible polymeric microspheres encapsulating Salmonella enteritidis bacteria' [patent_app_type] => utility [patent_app_number] => 09/958210 [patent_app_country] => US [patent_app_date] => 2000-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 3851 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132108.pdf [firstpage_image] =>[orig_patent_app_number] => 09958210 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/958210
Biodegradable and biocompatible polymeric microspheres encapsulating Salmonella enteritidis bacteria Feb 7, 2000 Issued
09/500147 Botulinum toxin pharmaceutical compositions Feb 7, 2000 Abandoned
Array ( [id] => 6741233 [patent_doc_number] => 20030158602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'NELL-1 ENHANCED BONE MINERALIZATION' [patent_app_type] => new [patent_app_number] => 09/412297 [patent_app_country] => US [patent_app_date] => 1999-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17595 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158602.pdf [firstpage_image] =>[orig_patent_app_number] => 09412297 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/412297
NELL-1 enhanced bone mineralization Oct 4, 1999 Issued
Array ( [id] => 101886 [patent_doc_number] => 07722887 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-05-25 [patent_title] => 'Detoxified mutants of escherichia coli heat-labile enterotoxin' [patent_app_type] => utility [patent_app_number] => 10/088202 [patent_app_country] => US [patent_app_date] => 1999-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7208 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/722/07722887.pdf [firstpage_image] =>[orig_patent_app_number] => 10088202 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/088202
Detoxified mutants of escherichia coli heat-labile enterotoxin Sep 14, 1999 Issued
Array ( [id] => 303307 [patent_doc_number] => 07534443 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-05-19 [patent_title] => 'Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient' [patent_app_type] => utility [patent_app_number] => 09/743750 [patent_app_country] => US [patent_app_date] => 1999-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 11079 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/534/07534443.pdf [firstpage_image] =>[orig_patent_app_number] => 09743750 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/743750
Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient Jul 15, 1999 Issued
Array ( [id] => 7612928 [patent_doc_number] => 06902906 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-07 [patent_title] => 'Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines' [patent_app_type] => utility [patent_app_number] => 09/646925 [patent_app_country] => US [patent_app_date] => 1999-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 8350 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/902/06902906.pdf [firstpage_image] =>[orig_patent_app_number] => 09646925 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/646925
Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines Mar 24, 1999 Issued
Array ( [id] => 634004 [patent_doc_number] => 07129060 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-31 [patent_title] => 'Export systems for recombinant proteins' [patent_app_type] => utility [patent_app_number] => 09/147036 [patent_app_country] => US [patent_app_date] => 1996-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 10841 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129060.pdf [firstpage_image] =>[orig_patent_app_number] => 09147036 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/147036
Export systems for recombinant proteins Mar 14, 1996 Issued
Menu